Continuous Wireless Monitoring of Vital Signs and Automated Alerts in Participants at Home and During Hospitalization
WARD Prospective Study - Continuous Wireless Monitoring of Vital Signs and Automated Alerts in Participants at Home and During Hospitalization
University Hospital Bispebjerg and Frederiksberg
3,095 participants
Feb 1, 2021
OBSERVATIONAL
Conditions
Summary
The primary aim of this study is to test and assess the implementation and effectiveness of continuous wireless vital signs monitoring with real-time alerts on: The frequency of patients monitored with adequate data quality as adequate clinical user satisfaction in the initial versus the last part of the trial (primary outcome).
Eligibility
Inclusion Criteria3
- Adult participants (≥18 years)
- Patients assessed by the clinical staff as having an acute condition with risk for clinical deterioration and being either at home (with no apparent need for hospitalization), and/or in hospital OR
- Patients at either at home before, in-hospital and/or after hospitalization for elective major surgery, defined as surgery lasting more than one hour under general- or regional anaesthesia
Exclusion Criteria4
- The participant expected not to cooperate with study procedures.
- Allergy to plaster or silicone.
- Having pacemaker or Implantable Cardioverter Defibrillator (ICD) device.
- Inability to give informed consent.
Interventions
Patients vital signs are monitored through an app for the nurses to use
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05378139